,Set,N,DE,P.DE,FDR,DEG.GENES
1,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,22,3,1.06463668754427e-05,0.00883648450661746,PLTP,LDLR,ABCA1
2,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,11,2,0.00020579048996053,0.0402715901126622,PLTP,LDLR
3,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,11,2,0.00020579048996053,0.0402715901126622,PLTP,LDLR
4,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,12,2,0.000246640206243195,0.0402715901126622,PLTP,LDLR
5,WP_CHOLESTEROL_METABOLISM,62,3,0.000247522261442754,0.0402715901126622,PLTP,LDLR,ABCA1
6,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,13,2,0.000291119928525269,0.0402715901126622,PLTP,LDLR
7,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,15,2,0.000390914355341407,0.0405573643666709,PLTP,LDLR
8,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,2,0.000390914355341407,0.0405573643666709,LDLR,ABCA1
9,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,16,2,0.000446201636701497,0.0411497064958047,LDLR,ABCA1
10,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,32,2,0.00180784889860678,0.145030220924459,LDLR,ABCA1
11,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,33,2,0.00192208726526392,0.145030220924459,C3,PRKCB
12,WP_VITAMIN_B12_METABOLISM,40,2,0.00281479481696382,0.194689974839997,LDLR,ABCA1
13,WP_GPCRS_OTHER,46,2,0.00370722612903873,0.236692129777088,CCR5,ADRB2
14,WP_FOLATE_METABOLISM,52,2,0.00471423541836902,0.250491029913255,LDLR,ABCA1
15,WP_PPAR_SIGNALING,52,2,0.00471423541836902,0.250491029913255,PLTP,CPT1B
16,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,349,4,0.00482874274531576,0.250491029913255,PLTP,LDLR,ABCA1,CPT1B
17,WP_ONCOSTATIN_M_SIGNALING,62,2,0.00663992299116623,0.324184475451057,LDLR,PRKCB
18,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,67,2,0.00771551088635598,0.324939059702982,TLR4,PRKCB
19,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,69,2,0.00816631641259153,0.324939059702982,C3,TLR4
20,WP_SELENIUM_MICRONUTRIENT_NETWORK,69,2,0.00816631641259153,0.324939059702982,LDLR,ABCA1
21,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,5,1,0.00980613483340254,0.324939059702982,TLR4
22,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,5,1,0.00980613483340254,0.324939059702982,AKR1C1
23,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,78,2,0.0103372978602767,0.324939059702982,TLR4,PRKCB
24,WP_GLIOBLASTOMA_SIGNALING,80,2,0.0108508193700754,0.324939059702982,BRCA2,PRKCB
25,WP_ACUTE_VIRAL_MYOCARDITIS,81,2,0.0111117494701421,0.324939059702982,CCR5,TLR4
26,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,6,1,0.011756066488363,0.324939059702982,LDLR
27,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,1,0.011756066488363,0.324939059702982,C3
28,WP_IRINOTECAN_PATHWAY,6,1,0.011756066488363,0.324939059702982,CYP3A5
29,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,6,1,0.011756066488363,0.324939059702982,CTDSP1
30,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,1,0.011756066488363,0.324939059702982,TLR4
31,WP_WNT_SIGNALING_AND_PLURIPOTENCY,86,2,0.0124576389350832,0.324939059702982,LDLR,PRKCB
32,WP_NUCLEAR_RECEPTORS_METAPATHWAY,252,3,0.0133207200183778,0.324939059702982,PLTP,CES3,CYP3A5
33,WP_SPINAL_CORD_INJURY,90,2,0.0135831613028213,0.324939059702982,TLR4,RHOB
34,WP_BENZOAPYRENE_METABOLISM,7,1,0.0137022495055474,0.324939059702982,AKR1C1
35,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,7,1,0.0137022495055474,0.324939059702982,PRKCB
36,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,1,0.0156446909160681,0.337247829479107,TLR4
37,WP_LIPID_PARTICLES_COMPOSITION,8,1,0.0156446909160681,0.337247829479107,LDLR
38,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,8,1,0.0156446909160681,0.337247829479107,ADRB2
39,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,269,3,0.0158465847586568,0.337247829479107,ADRB2,AKR1C1,PRKCB
40,WP_MINERALOCORTICOID_BIOSYNTHESIS,9,1,0.0175833977381796,0.352179410677367,AKR1C1
41,WP_TAMOXIFEN_METABOLISM,9,1,0.0175833977381796,0.352179410677367,CYP3A5
42,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,109,2,0.0194993929980988,0.352179410677367,ADRB2,PRKCB
43,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,1,0.0195183769772999,0.352179410677367,C3
44,WP_GANGLIO_SPHINGOLIPID_METABOLISM,10,1,0.0195183769772999,0.352179410677367,ST3GAL5
45,WP_GLUCOCORTICOID_BIOSYNTHESIS,10,1,0.0195183769772999,0.352179410677367,AKR1C1
46,WP_SEROTONIN_AND_ANXIETY,10,1,0.0195183769772999,0.352179410677367,PRKCB
47,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,114,2,0.0212067806326684,0.356063951392164,AKR1C1,CYP3A5
48,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,11,1,0.021449635626034,0.356063951392164,TLR4
49,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,11,1,0.021449635626034,0.356063951392164,ADRB2
50,WP_NEUROINFLAMMATION,11,1,0.021449635626034,0.356063951392164,TLR4
